Cynthia Lynn Anderson

This profile gathers the share dealings of Cynthia Lynn Anderson in VistaGen Therapeutics, Inc. Over a trading history stretching from 28 June 2024 to 30 June 2025, the count stands at 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 1 July 2025 came the latest disclosure, a share grant for €9,543 in VistaGen Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.